| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/14/2011 | CN102178720A Method for simultaneously preparing total saponin and polysaccharide from fiveleaf gynostemma herb |
| 09/14/2011 | CN102178714A Preparation for improving oral adsorption of panax notoginsenosides and preparation method thereof |
| 09/14/2011 | CN102178699A Preparation for enhancing human immunity and promoting growth and development |
| 09/14/2011 | CN102178686A Medicament and vaccine for polysaccharide-related disease and immunoassay product |
| 09/14/2011 | CN102178683A Application of taurochenodeoxycholic acid to protection of gastrointestinal tract function |
| 09/14/2011 | CN102178674A Use of oridonin in preparation of medicines for generating immunodepression effect |
| 09/14/2011 | CN102178647A Pranlukast injection preparation |
| 09/14/2011 | CN102178425A Pollen typhael medicinal pillow |
| 09/14/2011 | CN102178193A Chinese wolfberry fruit powder and preparation method thereof |
| 09/14/2011 | CN101856427B Method for extracting solanine from potato peels |
| 09/14/2011 | CN101856382B Novel method for extracting and separating platycodin effective ingredients |
| 09/14/2011 | CN101829211B Fish compound traditional Chinese medicinal preparation and preparation method thereof |
| 09/14/2011 | CN101757451B Natural plant preparation for promoting nutrition rehabilitation of mucous membrane of animal and preparing method thereof |
| 09/14/2011 | CN101732564B Anticancer traditional Chinese medicine composition, preparation method and application thereof |
| 09/14/2011 | CN101612386B Application of active peptide of deer blood in preparing antihypertensive medicaments and health care products |
| 09/14/2011 | CN101580546B Human anti human interferon alpha antibody and application thereof |
| 09/14/2011 | CN101579352B Application of polysaccharide component of longan pulp in pharmacy |
| 09/14/2011 | CN101536978B Carboxymethyl starch sodium oral solution and preparation method thereof |
| 09/14/2011 | CN101524492B Traditional Chinese peroral preparation with immunity-strengthening function and preparation method thereof |
| 09/14/2011 | CN101455844B PEG-erythrocyte-stimulating factor and preparation method and use thereof |
| 09/14/2011 | CN101302491B Highly effective method for amplifying activated lymphocyte and cultivation system |
| 09/14/2011 | CN101199626B Powders medicament for treating anal eczema |
| 09/14/2011 | CN101168050B Immunity regulating medicinal composition |
| 09/13/2011 | US8019557 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 09/13/2011 | US8017726 Anti-inflammatory compounds and uses thereof |
| 09/13/2011 | US8017725 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 09/13/2011 | US8017643 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 09/13/2011 | US8017628 Pharmaceutically active sulfonyl hydrazide derivatives |
| 09/13/2011 | US8017596 Phosphonates useful as modulators of T-γ-9-δ-2 activity |
| 09/13/2011 | US8017590 Method of inducing and/or enhancing an immune response to tumor antigens |
| 09/13/2011 | US8017587 2-O- (β-D-glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 09/13/2011 | US8017581 MSH-agonist tripeptide conjugates |
| 09/13/2011 | US8017392 Hox11+, CD45− cells and methods of organ regeneration using the same |
| 09/13/2011 | US8017125 Copolymers for suppression of autoimmune diseases, and methods of use |
| 09/13/2011 | CA2350519C Chromone enteric release formulation |
| 09/13/2011 | CA2297101C Receptor specific transepithelial transport of therapeutics |
| 09/13/2011 | CA2250792C Cocoa extract compounds and methods for making and using the same |
| 09/12/2011 | CA2697887A1 Modulating and/or detecting activation induced deaminase and methods of use thereof |
| 09/09/2011 | WO2011109471A1 Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
| 09/09/2011 | WO2011109470A1 Heteroaryl nitrile compounds useful as inhibitors of cathepsin-s |
| 09/09/2011 | WO2011109355A1 Compounds for immunoproteasome inhibition |
| 09/09/2011 | WO2011109338A1 Methods and compositions for treating degos' disease |
| 09/09/2011 | WO2011109324A1 Tetrazole compounds which selectively modulate the cb2 receptor |
| 09/09/2011 | WO2011109280A1 Methods and compositions to treat immune-mediated disorders |
| 09/09/2011 | WO2011108714A1 Antibody constant region variant |
| 09/09/2011 | WO2011108689A1 Pyrazolopyrimidine derivative |
| 09/09/2011 | WO2011108681A1 Anti-allergic agent, and method for producing same |
| 09/09/2011 | WO2011108425A1 Immunomodulator preparation method and immunomodulator |
| 09/09/2011 | WO2011108275A1 Immunoglobulin a secretion promoter |
| 09/09/2011 | WO2011107590A1 Cnn1 (cyr61) for prevention and therapy of inflammatory disease |
| 09/09/2011 | WO2011107585A1 Morpholino substituted urea derivatives as mtor inhibitors |
| 09/09/2011 | WO2011107553A1 Antibodies against human csf-1r and uses thereof |
| 09/09/2011 | WO2011107295A1 Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms |
| 09/09/2011 | WO2011107248A1 NOVEL COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ GAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASE |
| 09/09/2011 | WO2011106885A1 Oligomer-specific amyloid beta epitope and antibodies |
| 09/09/2011 | WO2011106867A1 Tunicate extracts and uses thereof in anti-allergy applications |
| 09/09/2011 | WO2011079308A3 Compositions comprising tnf-alpha and il-6 antagonists and methods of use thereof |
| 09/09/2011 | WO2011037433A3 Use of a quinolone derivative containing 7-(4-aminomethyl-3-oxime)pyrrolidine group that is capable of inducing granulocyte colony stimulating factor for treatment of neutropenia and recovery of hematopoiesis |
| 09/09/2011 | CA2792258A1 Induced dendritic cell compositions and uses thereof |
| 09/09/2011 | CA2792102A1 Pyrazolopyrimidine derivative |
| 09/09/2011 | CA2791962A1 Methods and compositions for treating degos' disease |
| 09/09/2011 | CA2791711A1 Treatment of lupus arthritis using laquinimod |
| 09/09/2011 | CA2791709A1 Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate |
| 09/09/2011 | CA2791691A1 Treatment of lupus nephritis using laquinimod |
| 09/09/2011 | CA2791651A1 Compounds for immunoproteasome inhibition |
| 09/09/2011 | CA2791538A1 Oligomer-specific amyloid beta epitope and antibodies |
| 09/09/2011 | CA2791327A1 Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms |
| 09/09/2011 | CA2789480A1 Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
| 09/09/2011 | CA2789076A1 Antibodies against human csf-1r and uses thereof |
| 09/08/2011 | US20110218343 Small molecule inhibitors of rotamase enzyme activity |
| 09/08/2011 | US20110218329 Anti-il-6 antibodies, compositions, methods and uses |
| 09/08/2011 | US20110218248 Organic compounds |
| 09/08/2011 | US20110218234 Gene vector for inducing transgene-specific immune tolerance |
| 09/08/2011 | US20110218230 Natriuretic peptide related fragment in cardiovascular disease |
| 09/08/2011 | US20110218219 Substituted sulphonamido phenoxybenzamides |
| 09/08/2011 | US20110218179 Treatment of lupus nephritis using laquinimod |
| 09/08/2011 | US20110218171 Trehalose compound, method for producing same, and pharmaceutical product containing the compound |
| 09/08/2011 | US20110218157 Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome |
| 09/08/2011 | US20110218138 Pharmaceutical composition containing polypeptide fragments of serralysins |
| 09/08/2011 | US20110217772 Animal protein free media for cultivation of cells |
| 09/08/2011 | US20110217749 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 09/08/2011 | US20110217402 Probiotic Derived Non-Viable Material For Allergy Prevention And Treatment |
| 09/08/2011 | US20110217394 Iridoid Based Formulations |
| 09/08/2011 | US20110217376 Poly(amidoamine) oligomer hydrogel for drug delivery and drug carrier using the same |
| 09/08/2011 | US20110217366 Immunopotentiating composition |
| 09/08/2011 | US20110217364 Conjugated suramin amino compounds for medical conditions |
| 09/08/2011 | US20110217338 HIV-1 Envelope Based Fragments |
| 09/08/2011 | US20110217335 Synthesis of resorcylic acid lactones useful as therapeutic agents |
| 09/08/2011 | US20110217334 Hypoallergenic molecules |
| 09/08/2011 | US20110217332 Chimpanzee Adenovirus Vaccine Carriers |
| 09/08/2011 | US20110217330 Novel method |
| 09/08/2011 | US20110217329 Vaccine |
| 09/08/2011 | US20110217327 Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs |
| 09/08/2011 | US20110217326 Method for diagnosing and/or treating tumor |
| 09/08/2011 | US20110217325 T cell epitopes of the cyn d 1 allergen from bermuda grass pollen |
| 09/08/2011 | US20110217324 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof |
| 09/08/2011 | US20110217323 Imidazoquinoline compounds |
| 09/08/2011 | US20110217316 GBS Toxin Receptor Compositions and Methods of Use |
| 09/08/2011 | US20110217302 TCR Complex Immunotherapeutics |
| 09/08/2011 | US20110217295 Treatment of lupus arthritis using laquinimod |